Paul Kaywin

619 total citations
10 papers, 505 citations indexed

About

Paul Kaywin is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Paul Kaywin has authored 10 papers receiving a total of 505 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 3 papers in Surgery and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Paul Kaywin's work include Neutropenia and Cancer Infections (3 papers), Heparin-Induced Thrombocytopenia and Thrombosis (2 papers) and Platelet Disorders and Treatments (2 papers). Paul Kaywin is often cited by papers focused on Neutropenia and Cancer Infections (3 papers), Heparin-Induced Thrombocytopenia and Thrombosis (2 papers) and Platelet Disorders and Treatments (2 papers). Paul Kaywin collaborates with scholars based in United States. Paul Kaywin's co-authors include Alan D. Schreiber, Douglas B. Cines, Sanford J. Shattil, Paul A. Insel, CD Buckner, CH Weaver, B Zhen, B Hazelton, K Longin and Barth D. Grant and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Paul Kaywin

10 papers receiving 449 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paul Kaywin United States 8 297 190 115 100 78 10 505
Yavuz M. Bilgin Netherlands 13 135 0.5× 142 0.7× 41 0.4× 20 0.2× 90 1.2× 32 604
Krzysztof Chojnowski Poland 15 356 1.2× 87 0.5× 207 1.8× 79 0.8× 55 0.7× 73 704
Silvia Vettore Italy 17 475 1.6× 109 0.6× 105 0.9× 103 1.0× 114 1.5× 39 719
AB Federici Italy 11 657 2.2× 158 0.8× 110 1.0× 31 0.3× 70 0.9× 22 789
V Deutsch Israel 12 120 0.4× 175 0.9× 120 1.0× 41 0.4× 114 1.5× 48 571
Yonca Eğin Türkiye 14 213 0.7× 70 0.4× 77 0.7× 63 0.6× 63 0.8× 50 417
Tamara Brunelli Italy 15 187 0.6× 146 0.8× 37 0.3× 32 0.3× 126 1.6× 25 611
O.S. Roath United Kingdom 12 83 0.3× 59 0.3× 49 0.4× 40 0.4× 38 0.5× 26 337
Ece Akar Türkiye 15 334 1.1× 142 0.7× 85 0.7× 102 1.0× 86 1.1× 49 679
P. Arcieri Italy 13 455 1.5× 47 0.2× 61 0.5× 41 0.4× 41 0.5× 16 667

Countries citing papers authored by Paul Kaywin

Since Specialization
Citations

This map shows the geographic impact of Paul Kaywin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Kaywin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Kaywin more than expected).

Fields of papers citing papers by Paul Kaywin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Kaywin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Kaywin. The network helps show where Paul Kaywin may publish in the future.

Co-authorship network of co-authors of Paul Kaywin

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Kaywin. A scholar is included among the top collaborators of Paul Kaywin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Kaywin. Paul Kaywin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
2.
Kotecha, Rupesh, Raees Tonse, Muni Rubens, et al.. (2021). Meta-Analysis of Survival and Development of a Prognostic Nomogram for Malignant Pleural Mesothelioma Treated with Systemic Chemotherapy. Cancers. 13(9). 2186–2186. 9 indexed citations
3.
Blakely, Johnetta, Frederick M. Schnell, Paul Kaywin, et al.. (2006). Phase II trial of pemetrexed (P) and gemcitabine (G) as first-line chemotherapy for elderly and/or poor performance status patients with stage IIIB/IV non-small cell lung cancer (NSCLC). Journal of Clinical Oncology. 24(18_suppl). 17031–17031. 4 indexed citations
4.
Saven, Alan, L. Schwartzberg, Paul Kaywin, et al.. (2006). Randomized, double-blind, phase 2, study evaluating same-day vs next-day administration of pegfilgrastim with R-CHOP in non-Hodgkin’s lymphoma patients. Journal of Clinical Oncology. 24(18_suppl). 7570–7570. 16 indexed citations
5.
Perez, Edith A., et al.. (1998). Comparable safety and antiemetic efficacy of a brief (30-second bolus) intravenous granisetron infusion and a standard (15-minute) intravenous ondansetron infusion in breast cancer patients receiving moderately emetogenic chemotherapy.. PubMed. 4(1). 52–8. 16 indexed citations
6.
Weaver, CH, Janice Redmond, Paul Kaywin, et al.. (1997). Engraftment and outcomes of patients receiving myeloablative therapy followed by autologous peripheral blood stem cells with a low CD34+ cell content. Bone Marrow Transplantation. 19(11). 1103–1110. 52 indexed citations
7.
Weaver, CH, Lee S. Schwartzberg, B Zhen, et al.. (1997). High-dose chemotherapy and peripheral blood stem cell infusion in patients with non-Hodgkin’s lymphoma: results of outpatient treatment in community cancer centers. Bone Marrow Transplantation. 20(9). 753–760. 25 indexed citations
8.
Cines, Douglas B., et al.. (1980). Heparin-Associated Thrombocytopenia. New England Journal of Medicine. 303(14). 788–795. 219 indexed citations
9.
Kaywin, Paul, et al.. (1979). Pathophysiology of heparin-induced thrombocytopenia. Blood. 54. 1 indexed citations
10.
Kaywin, Paul, et al.. (1978). Platelet Function in Essential Thrombocythemia. New England Journal of Medicine. 299(10). 505–509. 152 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yavuz M. Bilgin Breakdown of academic impact, for papers by Krzysztof Chojnowski Breakdown of academic impact, for papers by Silvia Vettore Breakdown of academic impact, for papers by AB Federici Breakdown of academic impact, for papers by V Deutsch Breakdown of academic impact, for papers by Yonca Eğin Breakdown of academic impact, for papers by Tamara Brunelli Breakdown of academic impact, for papers by O.S. Roath Breakdown of academic impact, for papers by Ece Akar Breakdown of academic impact, for papers by P. Arcieri
Rankless by CCL
2026